‫تقرير بحث‬

‫حول‪:‬‬
‫‪information for laboratories about‬‬
‫‪coronavirus diagnosis test‬‬
‫تقديم الطالب ‪:‬‬
‫محمد علي حريج كشكول‬
‫المرحلة ‪ :‬الرابعة ‪ -‬مسائي‬
‫بأشراف ‪ :‬أ‪.‬م‪.‬د‪.‬نضال يوسف محمد‬
 INTRODUCTION

In December 2019, a mass outbreak of Coronavirus disease

2019 (COVID-19) occurred in Wuhan, Hubei Province, People’s
Republic of China. Currently, the disease has spread to other
regions of China and around the world [1]. In Korea, more than
9,000 patients have been confirmed as of March 25, 2020.
The World Health Organization (WHO) officially changed the
name of the disease to coronavirus disease 2019 (COVID-19)
from 2019 novel coronavirus (2019-nCoV) infection on February
11, 2020. The International Committee on Taxonomy of Viruses
has proposed the name severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) for the causative agent of
COVID-19 [2]. This document uses COVID-19 and SARS-CoV-2,
as well as 2019-nCoV infection as appropriate.
This document provides guidelines for diagnosing COVID-19
in human specimens. Some contents of this document, including
new test methods, specimen selection, and biosafety recommendations,
may be subject to revision later, with the emergence
of new scientific evidence and based on expert review.
The guidelines presented here are based on the “Korea Laboratory
Response and Preparedness for 2019 Novel Coronavirus
Molecular Testing in Clinical Laboratories” project, which is a
commissioned project aimed at establishing and managing COVID-
19 diagnosis in hospital laboratories and commercial laboratory
centers. All copyrights to these guidelines are owned by
Korean Society for Laboratory Medicine (KSLM) and the Korea
Centers for Disease Control and Prevention (KCDC).